Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide oral suspension vs placebo in pediatric eosinophilic esophagitis
2017-003737-29Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing Budesonide oral suspension with Placebo (2 arms). Started Dec 2018; status: completed.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2017-003737-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003737-29.